- Home
- SUZ vs CAI Comparison
SUZ vs CAI Comparison
Compare SUZ & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUZ
- CAI
- Stock Information
- Founded
- SUZ 1924
- CAI 2008
- Country
- SUZ Brazil
- CAI United States
- Employees
- SUZ N/A
- CAI N/A
- Industry
- SUZ Paper
- CAI Medical Specialities
- Sector
- SUZ Basic Materials
- CAI Health Care
- Exchange
- SUZ Nasdaq
- CAI Nasdaq
- Market Cap
- SUZ 12.1B
- CAI 10.1B
- IPO Year
- SUZ N/A
- CAI 2025
- Fundamental
- Price
- SUZ $9.73
- CAI $37.94
- Analyst Decision
- SUZ
- CAI Strong Buy
- Analyst Count
- SUZ 0
- CAI 6
- Target Price
- SUZ N/A
- CAI $35.50
- AVG Volume (30 Days)
- SUZ 1.5M
- CAI 723.5K
- Earning Date
- SUZ 10-23-2025
- CAI 08-12-2025
- Dividend Yield
- SUZ 2.72%
- CAI N/A
- EPS Growth
- SUZ 3585.36
- CAI N/A
- EPS
- SUZ 1.16
- CAI N/A
- Revenue
- SUZ $9,414,799,585.00
- CAI $533,847,000.00
- Revenue This Year
- SUZ $9.16
- CAI $59.70
- Revenue Next Year
- SUZ $17.10
- CAI $50.34
- P/E Ratio
- SUZ $8.31
- CAI N/A
- Revenue Growth
- SUZ 27.38
- CAI 106.53
- 52 Week Low
- SUZ $8.41
- CAI $25.40
- 52 Week High
- SUZ $10.98
- CAI $42.50
- Technical
- Relative Strength Index (RSI)
- SUZ 52.44
- CAI N/A
- Support Level
- SUZ $9.65
- CAI N/A
- Resistance Level
- SUZ $9.87
- CAI N/A
- Average True Range (ATR)
- SUZ 0.14
- CAI 0.00
- MACD
- SUZ -0.02
- CAI 0.00
- Stochastic Oscillator
- SUZ 36.12
- CAI 0.00
About SUZ Suzano S.A.
Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.
About CAI Caris Life Sciences Inc. Common Stock
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.